市場調查報告書
商品編碼
1499395
電外科市場:按產品類型、應用和最終用戶分類 - 全球預測 2024-2030Electrosurgery Market by Product (Accessories, Argon Systems, Generators), Type (Bipolar Electrosurgical Devices, Monopolar Electrosurgery), Application, End User - Global Forecast 2024-2030 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
預計2023年電外科市場規模為70.9億美元,預計2024年將達75.1億美元,2030年將達到107.5億美元,複合年成長率為6.13%。
電外科手術是一種常用高頻電流切割組織或止血的醫療手術。此手術使用一種專用的設備,使電流穿過患者的組織,對其進行加熱並達到所需的效果:切割、凝固、乾燥和凝固組織。這種方法與傳統手術不同,因為它出血較少,並且允許外科醫生做出更精確的切口。電外科可用於各種醫療環境,包括皮膚和心臟手術以及腫瘤切除。由於癌症和心血管疾病等需要手術干預的疾病的增加,電外科技術的使用正在擴大。隨著患者擴大尋求恢復時間更短、術後疼痛更少的手術,對支持微創手術的電外科手術的需求正在顯著增加。此外,醫療保健基礎設施支出的增加,特別是在新興國家,正在擴大先進外科技術(包括電外科技術)的取得和採用。然而,與先進電外科設備相關的高成本可能會限制市場滲透,特別是在成本敏感的市場。此外,電燒燙傷和電擊等併發症也會帶來風險,這可能會阻礙某些地區的採用。此外,電外科設備的技術創新,例如排煙系統和氬離子凝固方法的開發,透過提高外科手術的安全性和有效性,為市場成長提供了良好的機會。
主要市場統計 | |
---|---|
基準年[2023] | 70.9億美元 |
預測年份 [2024] | 75.1億美元 |
預測年份 [2030] | 107.5億美元 |
複合年成長率(%) | 6.13% |
區域洞察
美國市場因其先進的醫療基礎設施、大量的研發投資以及創新手術技術的高採用率而成為電外科領域的領導者。該市場是由領先的醫療設備公司推動的,這些公司透過創新和新技術不斷增強其產品。例如,美洲正在進行的技術創新著重於提高電外科器械的安全性和有效性、降低燒燙傷風險和改善病患治療效果。歐盟國家受益於簡化新醫療設備核准流程的法律規範。正在進行的舉措旨在改善手術結果並儘量減少侵入性手術,這推動了對電外科的需求。該領域的研究通常著重於提高心臟病學和神經病學等複雜手術中電外科設備的準確性。中東地區市場發展迅速,其中海灣國家由於醫療保健投資增加和醫療旅遊增加而引領成長。儘管非洲在技術採用方面仍在發展,但隨著醫療基礎設施的改善和醫療設施的國際投資,它正在顯示出潛力。在亞太地區,中國、日本和印度因其人口眾多且醫療保健產業不斷發展而成為電外科市場的重要國家。該地區持續不斷的創新旨在開發具有成本效益的電外科設備,可廣泛用於各種醫療手術。政府對醫療改革的支持和高科技醫療設備的採用是這一成長的主要推動力。
FPNV定位矩陣
FPNV 定位矩陣對於評估供應商在電外科市場的定位至關重要。此矩陣提供了對供應商的全面評估,並檢驗了與業務策略和產品滿意度相關的關鍵指標。這種詳細的評估使用戶能夠根據自己的要求做出明智的決定。根據評估結果,供應商被分為代表其成功程度的四個像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市場佔有率分析
市場佔有率分析是一種綜合工具,可以對電外科市場供應商的現狀進行深入而詳細的評估。透過仔細比較和分析供應商的貢獻,您可以更深入地了解每個供應商的績效以及他們在爭奪市場佔有率時面臨的挑戰。這些貢獻包括整體收益、客戶群和其他重要指標。此外,該分析還提供了對該行業競爭性質的寶貴見解,包括在研究基準年期間觀察到的累積、分散主導地位和合併特徵等因素。有了這些詳細資訊,供應商可以做出更明智的決策並製定有效的策略,以在市場競爭中保持領先地位。
策略分析與建議
策略分析對於尋求在全球市場站穩腳跟的組織至關重要。對當前電外科市場地位的全面評估使公司能夠做出符合其長期願望的明智決策。此關鍵評估涉及對組織的資源、能力和整體績效進行徹底分析,以確定核心優勢和需要改進的領域。
[191 Pages Report] The Electrosurgery Market size was estimated at USD 7.09 billion in 2023 and expected to reach USD 7.51 billion in 2024, at a CAGR 6.13% to reach USD 10.75 billion by 2030.
Electrosurgery is a medical procedure commonly used to cut tissue or to stop bleeding by using high-frequency electrical currents. The procedure involves using a specialized instrument that directs electrical currents through a patient's tissue, causing it to heat and achieve the desired effect, whether that is cutting, coagulating, desiccating, or fulgurating (shallow coagulation) tissue. This method is distinct from traditional surgery because there is less blood loss, and it allows surgeons to make more precise cuts. Electrosurgery can be used in a variety of medical circumstances, including surgeries involving skin and heart procedures and in the removal of tumors. The rising prevalence of disorders that require surgical intervention, such as cancers and cardiovascular diseases, expands the use of electrosurgery techniques. As patients seek procedures with shorter recovery times and less postoperative pain, the demand for electrosurgery, which supports minimally invasive techniques, significantly grows. Additionally, increased spending on healthcare infrastructure, particularly in emerging economies, expands the accessibility and adoption of advanced surgical technologies, including electrosurgery. However, high costs associated with advanced electrosurgical devices can limit market penetration, especially in cost-sensitive markets. Additionally, complications such as burns or shocks due to electric currents can pose risks, which may deter adoption in some regions. Furthermore, innovations in electrosurgery devices, such as the development of smoke evacuation systems and argon plasma coagulation, pose lucrative opportunities for market growth by improving the safety and effectiveness of surgical procedures.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 7.09 billion |
Estimated Year [2024] | USD 7.51 billion |
Forecast Year [2030] | USD 10.75 billion |
CAGR (%) | 6.13% |
Regional Insights
The American market is a leader in the electrosurgery field due to its advanced healthcare infrastructure, heavy investment in R&D, and high adoption of innovative surgical technologies. The extensive presence of major medical device companies, which continually enhance their products through innovation and new technologies, drives this market. For instance, ongoing innovations in the Americas have focused on enhancing the safety and effectiveness of electrosurgical instruments, reducing the risk of burns, and improving patient outcomes. Countries within the EU benefit from the collective regulatory framework that streamlines the approval processes for new medical devices. Ongoing initiatives aim to enhance surgical outcomes and minimize invasive procedures, which boosts the demand for electrosurgery. Research in this region often focuses on improving the precision of electrosurgical devices in complicated surgeries such as cardiology and neurology. The market in the Middle East region is rapidly evolving, with Gulf countries spearheading growth due to increasing healthcare investments and growing medical tourism. Africa, while still developing in terms of technology adoption, shows potential due to its enhanced healthcare infrastructure and international investment in medical facilities. In APAC, China, Japan, and India, with a large population and growing healthcare sector, make it a significant country in the electrosurgery market. Ongoing innovations in the region have aimed at creating cost-effective electrosurgical devices that can be widely used in various medical procedures. The government's push toward healthcare reform and the adoption of high-tech medical devices are significant drivers behind this growth.
Market Insights
The market dynamics represent an ever-changing landscape of the Electrosurgery Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
FPNV Positioning Matrix
The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Electrosurgery Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Electrosurgery Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Recent Developments
Stratus Medical Expands RF Technology Patents in Europe
Stratus Medical, a Texas-based company in radiofrequency (RF) technologies for chronic pain management, announced the expansion of their European patent portfolio. These patents reinforce the protection of the company's NIMBUS Electrosurgical RF Multitined Expandable Electrode in several key European markets including the United Kingdom, Ireland, and Spain, and extend through the Unitary Patent system to include France, Germany, Italy, and other participating nations. [Published On: 2024-04-29]
Olympus Launches the ESG-410 Generator for Enhanced Bladder and Prostate Care
Olympus Corporation has introduced the ESG-410 Electrosurgical Generator, a pivotal advancement for the treatment of non-muscle-invasive bladder cancer (NMIBC) and benign prostatic hyperplasia (BPH). This latest model is engineered with superior features, including larger capacitors for improved plasma stability, resulting in more efficient energy usage and quicker tissue removal during procedures. The ESG-410 boasts a significant upgrade over its predecessor, the ESG-400, with enhancements such as faster ignition, a larger 8.4-inch LCD touchscreen, and both wireless and wired foot pedal options. [Published On: 2023-06-05]
Breakthrough Designation for Innoblative's Innovative SIRA RFA Device in Breast Cancer Surgery
Innoblative Designs, Inc. has achieved a prestigious milestone by receiving the Breakthrough Device Designation from the U.S. FDA for its SIRA RFA Electrosurgical Device. The SIRA device is specifically crafted for breast cancer patients undergoing breast-conserving surgery (BCS), targeting an enhanced surgical outcome by potentially reducing the rates of reoperation. This innovation aims to standardize treatment results by ensuring uniform energy application, potentially minimizing local cancer recurrence. [Published On: 2023-04-27]
Strategy Analysis & Recommendation
The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Electrosurgery Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
Key Company Profiles
The report delves into recent significant developments in the Electrosurgery Market, highlighting leading vendors and their innovative profiles. These include Advin Health Care, Alcon Inc., AngioDynamics, Inc., Applied Medical Resources Corporation, Aspen Surgical Products, B. Braun SE, Baxter International Inc., Boston Scientific Corporation, CONMED Corporation, Cook Group Incorporated, Erbe Elektromedizin GmbH, Innoblative Designs, Inc., Integra LifeSciences, Intuitive Surgical, Inc., Johnson & Johnson Services, Inc., Karl Storz SE & Co. KG, KLS Martin SE & Co. KG, LED SpA, Medline Industries, LP, Medtronic PLC, Olympus Corporation, Smith & Nephew PLC, and Stryker Corporation.
Market Segmentation & Coverage